Psychiatric side effects of mefloquine: applications to forensic psychiatry

J Am Acad Psychiatry Law. 2013;41(2):224-35.

Abstract

Mefloquine (previously marketed in the United States as Lariam®) is an antimalarial medication with potent psychotropic potential. Severe psychiatric side effects due to mefloquine intoxication are well documented, including anxiety, panic attacks, paranoia, persecutory delusions, dissociative psychosis, and anterograde amnesia. Exposure to the drug has been associated with acts of violence and suicide. In this article, we discuss the history of mefloquine use and describe plausible mechanisms of its psychotropic action. Mefloquine intoxication has not yet been successfully advanced in legal proceedings as a defense or as a mitigating factor, but it appears likely that it eventually will be. Considerations for the application of claims of mefloquine intoxication in forensic settings are discussed.

MeSH terms

  • Adverse Drug Reaction Reporting Systems
  • Aggression / drug effects
  • Aggression / psychology
  • Antimalarials / therapeutic use
  • Antimalarials / toxicity*
  • Comorbidity
  • Contraindications
  • Diagnosis, Differential
  • Drug Labeling / legislation & jurisprudence
  • Expert Testimony / legislation & jurisprudence*
  • Humans
  • Insanity Defense*
  • Liability, Legal
  • Mefloquine / therapeutic use
  • Mefloquine / toxicity*
  • Mental Disorders / chemically induced*
  • Mental Disorders / diagnosis
  • Mental Disorders / psychology*
  • Neuropsychological Tests
  • Psychoses, Substance-Induced / diagnosis*
  • Psychoses, Substance-Induced / psychology*
  • Suicide / legislation & jurisprudence
  • Suicide / psychology
  • Violence / legislation & jurisprudence
  • Violence / psychology

Substances

  • Antimalarials
  • Mefloquine